Spruce Biosciences Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Spruce Biosciences Inc
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Frequently asked questions
To buy Spruce Biosciences Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Spruce Biosciences Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Spruce Biosciences Inc is SPRB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Spruce Biosciences Inc has its primary listing on NASDAQ (Small cap). You can trade Spruce Biosciences Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Spruce Biosciences Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Spruce Biosciences Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Spruce Biosciences Inc .